These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8181358)

  • 1. Malignant pleural effusion from prostatic adenocarcinoma resolved with hormonal therapy.
    Carrascosa M; Perez-Castrillon JL; Mendez MA; Cillero L; Valle R
    Chest; 1994 May; 105(5):1577-8. PubMed ID: 8181358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic pleural effusion as presenting sign of prostatic carcinoma.
    Druwé PM; Verresen DA; Van Meerbeeck JP; Van Marck EA; Vermeire PA
    Acta Clin Belg; 1995; 50(4):227-30. PubMed ID: 7483974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytology of metastatic adenocarcinoma of the prostate in pleural effusions.
    Renshaw AA; Nappi D; Cibas ES
    Diagn Cytopathol; 1996 Aug; 15(2):103-7. PubMed ID: 8872430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pleural effusion in lung cancer.
    Sahn SA
    Clin Chest Med; 1993 Mar; 14(1):189-200. PubMed ID: 8384963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal ablation as effective therapy for carcinomatous meningitis from prostatic carcinoma.
    Mencel PJ; DeAngelis LM; Motzer RJ
    Cancer; 1994 Apr; 73(7):1892-4. PubMed ID: 8137217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Utility of prostate-specific antigen in pleural fluid for the diagnosis of metastatic effusion secondary to prostate cancer].
    Sánchez Merino JM; Quintana González JI; Toribio Sánchez CM; Gómez Cisneros SC; Parra Muntaner L; García Alonso J
    Actas Urol Esp; 2002; 26(7):513-4. PubMed ID: 12224436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary tumour resection showed survival benefits for non-small-cell lung cancers with unexpected malignant pleural dissemination.
    Ren YJ; She YL; Dai CY; Jiang GN; Fei K; Chen C
    Interact Cardiovasc Thorac Surg; 2016 Mar; 22(3):321-6. PubMed ID: 26705302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Massive pleural effusion without bony involvement: an unusual presentation of advanced carcinoma prostate.
    Ansari MS; Nabi G; Seth A
    Indian J Cancer; 2002; 39(3):123-4. PubMed ID: 12928569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Massive pleural effusion due to metastasis of prostate cancer.
    dos Santos VM; Zembrzuski MM; Gouvea IP; Nery NS; dos Santos LA
    West Indian Med J; 2011 Dec; 60(6):690-3. PubMed ID: 22512233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostatic adenocarcinoma diagnosed by prostate-specific antigen analysis of pleural fluid.
    Brown GA; Ginsberg PC; Harkaway RC
    Urol Int; 1998; 60(3):197-8. PubMed ID: 9644796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 68Ga-Prostate-Specific Membrane Antigen Uptake in a Malignant Pleural Effusion From Metastatic Prostate Cancer After Pleurodesis.
    Sachpekidis C; Alberts I; Rominger A; Afshar-Oromieh A
    Clin Nucl Med; 2019 Oct; 44(10):838-839. PubMed ID: 31283614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of patients with androgen-independent prostatic carcinoma whose serum prostate specific antigen decreased following flutamide withdrawal.
    Herrada J; Dieringer P; Logothetis CJ
    J Urol; 1996 Feb; 155(2):620-3. PubMed ID: 8558675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic prostatic adenocarcinoma presenting as a pituitary mass: shrinkage of the lesion and clinical improvement with medical treatment.
    Losa M; Grasso M; Giugni E; Mortini P; Acerno S; Giovanelli M
    Prostate; 1997 Sep; 32(4):241-5. PubMed ID: 9288182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of flutamide in hormone-refractory metastatic prostate cancer.
    McLeod DG; Benson RC; Eisenberger MA; Crawford ED; Blumenstein BA; Spicer D; Spaulding JT
    Cancer; 1993 Dec; 72(12 Suppl):3870-3. PubMed ID: 8252506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent androgen suppression for locally advanced and metastatic prostate cancer: preliminary report of a prospective multicenter study.
    Sato N; Akakura K; Isaka S; Nakatsu H; Tanaka M; Ito H; Masai M;
    Urology; 2004 Aug; 64(2):341-5. PubMed ID: 15302491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pleural effusion as presentation of metastatic adenocarcinoma of prostate.
    de Paso Mora PG; Ríos BJ; Pascual Pareja FJ; Castillo Torres C; Pinto Marín A; Sendino Revuelta A; Vázquez RJ
    South Med J; 2005 Sep; 98(9):959-60. PubMed ID: 16218001
    [No Abstract]   [Full Text] [Related]  

  • 17. EUS-guided fine needle tissue acquisition for the diagnosis of pleural metastases from endometrial cancer.
    Larghi A; Lococo F; Mainenti S; Petrone G; Cesario A; Granone P; Scambia G; Costamagna G
    Eur Rev Med Pharmacol Sci; 2014; 18(9):1379-82. PubMed ID: 24867517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic prostatic adenocarcinoma mimicking inflammatory breast carcinoma: a case report.
    Njiaju UO; Truica CI
    Clin Breast Cancer; 2010 Feb; 10(1):E3-5. PubMed ID: 20133250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pleural effusion resulting from metastatic papillary carcinoma of the thyroid.
    Vernon AN; Sheeler LR; Biscotti CV; Stoller JK
    Chest; 1992 May; 101(5):1448-50. PubMed ID: 1582317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thoracoscopy in malignant pleural effusions].
    Zhang D; Chen Y; Tu C
    Zhonghua Zhong Liu Za Zhi; 1996 Mar; 18(2):123-6. PubMed ID: 9206045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.